ImmunoGen, J&amp;J unit agree to licensing deal
456954
ImmunoGen Inc. of Cambridge is expected to disclose today that it is licensing its cancer-fighting technology to Centocor Inc. , a biotech subsidiary of healthcare giant Johnson &amp; Johnson Inc.
566278
Merck & Co Inc's Gardasil, the first  vaccine to prevent cervical cancer, has been approved for sale  in the Europe Union, the joint venture that will market the  product in Europe said on Friday.
560221
J&J gains pediatric approval of its antipsychosic drug.
26798
Early yesterday evening, Biogen IDEC (Nasdaq: BIIB) and Elan (NYSE: ELN) announced that Tysabri had been approved by the FDA for the treatment of multiple sclerosis (MS).
17093
ID Biomedical Corp. (IDB.TO: Quote, Profile, Research) (IDBE.O: Quote, Profile, Research) signed a 10-year US distribution deal for its Fluviral drug that could reap
260762
Shares of ID Biomedical jumped after the Canadian drug maker reported Monday that it signed long-term agreements with the three largest flu vaccine wholesalers in the United States following the current flu season&#39;s vaccine shortage.
770040
An experimental antibody drug being developed by Danish biotech company Genmab and Britain's GlaxoSmithKline Plc confirmed its promise as a rheumatoid arthritis treatment on Friday.
753694
Northwest Biotherapeutics, a US-based biotech company, said Monday it had won approval for commercial use of the world&#39;s first vaccine against brain cancer in Switzerland.
303789
Schering-Plough and Bayer have announced an agreement under which New Jersey-based Schering will attain US marketing rights to Bayer HealthCareâs primary care pharmaceutical products, including the antibiotics Avelox (moxifloxacin HCL) and Cipro
255760
Biogen Idec Inc., of Cambridge, had a remarkable 2004. Biogen had just finalized its $6.4 billion merger with Idec Corp., of San Diego, when it got word the Food and Drug Administration would consider its new multiple sclerosis drug on the basis of interim trial data, accelerating the approval timetable by a year. The company scrambled, applied on May 25, ...
334497
ID Biomedical Corp.   signed a 10-year U.S. distribution deal for its Fluviral drug that could reap sales of &#36;2.3 billion and help U.S. authorities fill a flu vaccine shortage, the company said on Monday.
297310
U.S. regulators have approved wider use of Genentech Inc. and Biogen Idec Inc.'s drug Rituxan for patients with a type of lymphoma, the companies announced on Friday.
502540
Johnson & Johnson  and Pfizer Inc.  have agreed to sell the U.S. rights to five brands, including anti-diarrhea drug Kaopectate, to Chattem Inc.  for $410 million to satisfy regulatory requirements, Chattem said on Friday.
318502
Lockheed Martin announced today it has entered into a license agreement with HMT Vehicles Ltd.
351992
In the latest endorsement of a science technique discovered at the University of Massachusetts, the international drug giant Roche signed a $331 million deal with Alnylam Pharmaceuticals Inc. of Cambridge for the rights to develop drugs using RNA interference.
641877
Health-care products maker Johnson &  Johnson  won U.S. approval to sell a new HIV drug called  Intelence for patients with resistance to other therapies, U.S.  officials said on Friday.
368114
Johnson &amp; Johnson announced last night that will buy medical-device maker Guidant for $23.9 billion in cash and stock. The deal, approved by both boards but subject to regulator approval, is one of the largest